![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Max-Planck-Institut für Infektionsbiologie, Abt. Molekulare Biologie, Schumannstr. 20/21, D-10117 Berlin, Germany
Received 15 December 2004/ Returned for modification 21 January 2005/ Accepted 24 March 2005
 |
ABSTRACT |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
INTRODUCTION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The major genetic difference between more virulent and less virulent H. pylori strains is the so-called cytotoxin-associated gene pathogenicity island (cag PAI). The cag PAI carries up to 31 genes which encode a type IV secretion system (TFSS) that appears to play a key role in H. pylori pathogenesis (2, 7). TFSSs enable bacteria to inject effector molecules into the cytoplasm of host cells (10, 26). In recent years, the function of the TFSS in the interaction of H. pylori with host cells has been studied intensively. The only protein known to be translocated by the H. pylori TFSS is the CagA protein, which is also encoded by a gene in the cag PAI. After translocation, CagA becomes phosphorylated on tyrosine residues by Src family kinases (34, 37) and induces rearrangements of the host cell actin cytoskeleton ("hummingbird phenotype") (32). CagA has been reported to interact with several host cell proteins and to stimulate various signaling processes in the host (25). Moreover, tyrosine-phosphorylated CagA inhibits c-Src, which leads to tyrosine dephosphorylation of the cellular Src substrates cortactin and ezrin (33, 35).
Besides the translocation of CagA, the H. pylori TFSS also mediates the induction of a proinflammatory response in host cells. Recently, it was shown that this involves the delivery of peptidoglycan to host cells via the TFSS (41). Translocated peptidoglycan is detected by the intracellular pathogen recognition molecule Nod1, which activates a signaling cascade leading to the activation of eukaryotic transcription factors such as nuclear factor kappa B (NF-
B). These transcription factors stimulate the synthesis and secretion of a range of inflammatory mediators, such as interleukin-8 (IL-8). Collectively, the combined effects of the cag PAI on the actin cytoskeleton and the proinflammatory responses of host cells are thought to play a central role in pathogenesis.
The H. pylori factors required for CagA translocation, the stimulation of IL-8 secretion, and induction of the hummingbird phenotype have been investigated by systematic mutagenesis of cag PAI genes (15, 36) and by comparisons of different clinical H. pylori isolates (5). A functional analysis of H. pylori strains lacking individual genes of the cag PAI has revealed that most genes are required for the induction of the proinflammatory response, changes in cellular morphology or shape, and CagA translocation. Much less is known about possible host cell components involved in these processes.
For this study, we investigated whether host cell determinants are required for the function of the H. pylori TFSS. For this purpose, we infected 19 different mammalian cell lines with wild-type H. pylori and isogenic knockout mutants of selected cag PAI genes. In order to determine the function of the TFSS, we monitored CagA translocation, host cell protein dephosphorylation, chemokine secretion, and changes in the cellular phenotype. Our findings provide the first clear experimental evidence of a role for different host factors in the induction of cag PAI-mediated responses.
|
MATERIALS AND METHODS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
cagA, P1virB11, and P12PAI have been described previously (6, 29). The cagA and virB11 genes correspond to the loci HP0547 and HP0525, respectively, in the database of The Institute for Genome Research (http://www.tigr.org). The P12PAI strain lacks the entire cag pathogenicity island. H. pylori wild-type strains were cultivated on horse serum agar plates supplemented with vancomycin (10 µg/ml). The mutants were cultivated on the same type of plates with additional chloramphenicol or kanamycin. Bacteria were incubated for 2 days at 37°C in an anaerobic jar containing a Campygen gas mix of 5% O2, 10% CO2, and 85% N2 (Oxoid). Eukaryotic cell lines. Nineteen different eukaryotic cell lines were analyzed for TFSS-dependent host cell responses (Table 1). Cells were grown in the indicated media and subcultured every 2 to 3 days.
|
SDS-PAGE and immunoblotting. Cell pellets with attached bacteria were mixed with equal amounts of 4x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer (125 mM Tris-HCl, pH 6.8, 200 mM SDS, 40% [vol/vol] glycerol, 10% [vol/vol] ß-mercaptoethanol, 0.4% bromphenol blue) and boiled for 5 min. Proteins were separated by SDS-PAGE in 6% or 10% polyacrylamide gels and blotted onto polyvinylidene difluoride membranes (Immobilon-P; Millipore) using standard protocols. Membranes were blocked in TBS-T (140 mM NaCl, 25 mM Tris-HCl, pH 7.4, 0.1% Tween 20) with 3% bovine serum albumin for 1 h at room temperature. Tyrosine-phosphorylated proteins were detected with the monoclonal phosphotyrosine-specific antibody PY99 (Santa Cruz Biotechnology) at a 1:3,000 dilution in TBS-T for 1 h at room temperature. CagA was detected with a rabbit anti-CagA antibody (Austral Biologicals). Blots were washed three times with TBS-T and incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit secondary antibodies (Amersham Pharmacia Biotech) for 1 h. After three more washing steps, the bound antibodies were detected with the Renaissance Western blot system for enhanced chemiluminescence immunostaining (ICN Biochemicals). The same blot was used for both anti-phosphotyrosine and anti-CagA immunoblotting. Between blotting procedures, the membranes were stripped for 30 min at 50°C in stripping buffer (62.5 mM Tris-HCl, pH 6.7, 100 mM 2-mercaptoethanol, 2% SDS).
Chemokine ELISA. The amounts of IL-8 and Mip-2 secreted into the cell culture medium after 20 h of infection were determined by a sandwich enzyme immunoassay using the ELISA systems of BioSource International for IL-8 detection and of R&D Systems for Mip-2 detection. The experiments were performed according to the manufacturer's instructions. Samples from at least three independent experiments were measured in triplicate. Due to differences in sequence or the absence of the IL-8 and Mip-2 genes, we were unable to detect chemokine secretion by the animal cell lines MDCK, Cos-1, and CHOK-1.
In vitro phosphorylation assay.
In order to investigate the ability of host cell lysates to phosphorylate CagA in vitro, we performed in vitro kinase assays. H. pylori wild-type strain P1 and the corresponding knockout mutant P1cagA were harvested from agar plates (optical density at 550 nm = 0.9) and resuspended in 2 ml cold kinase buffer (25 mM HEPES, pH 7.0, 150 mM NaCl, 10 mM MgCl2, 1% NP-40, 5 mM dithiothreitol, 1 mM Na3VO4, Complete protease inhibitors [Hoffmann-La Roche]). For bacterial lysis, the bacteria were sonicated on ice (Branson sonifier 450). Additionally, the bacteria were homogenized by 20 passages through a syringe. The eukaryotic cells were pelleted, resuspended in 1 ml cold kinase buffer, and lysed using a syringe as described above. Each bacterial lysate (50 µl) was mixed with 50 µl of the eukaryotic cell lysate. ATP was added to reach a final concentration of 40 µM. The reaction samples were incubated for 5 min at 30°C. To stop the phosphorylation reaction, we added 4x SDS-PAGE buffer and boiled the samples for 5 min. To monitor the in vitro phosphorylation of CagA, SDS-PAGE and immunoblotting were performed.
|
RESULTS |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
PAI). We did not detect CagA phosphorylation during the infection of HeLa, SYF+src, and GLC4 cells with H. pylori strain P12 (Fig. 1A, right panels). These results demonstrate that the observed host cell dependence of CagA phosphorylation also holds true for other H. pylori isolates besides P1. The differences between P1 and P12 are in agreement with the observation that bacterial factors play a critical role in functions mediated by the TFSS (5, 15, 36). Since we wanted to concentrate our study on differences between host cells rather than on differences between bacterial strains, we performed our subsequent experiments with a single well-characterized H. pylori isolate (strain P1). Notably, among the 19 cell lines tested, the highest level of CagA phosphorylation was observed with human gastric cell lines (Table 2). Most nongastric human cells showed decreased CagA phosphorylation. Finally, very weak or no CagA tyrosine phosphorylation was detected upon infection of most nonhuman cells.
|
An alternative explanation is that the differences in CagA phosphorylation are not directly correlated to differences in CagA translocation, but rather reflect variations in cellular kinase activity. In order to investigate this issue, we performed in vitro phosphorylation experiments with all 19 cell lines (Fig. 1B). We found that lysates from all cell lines were able to phosphorylate CagA in vitro. Thus, the variation in CagA tyrosine phosphorylation during infection evidently results from different levels of CagA translocation. Collectively, these results suggest that H. pylori does not arbitrarily inject CagA into any mammalian cell line. On the contrary, there is apparently some degree of cell type specificity involved in the process of type IV secretion.
Translocated CagA has been found to be processed into smaller fragments during infections of phagocytic cells (24, 29). Consistent with this observation, we also observed a p35CagA fragment in J774.A (Fig. 1C, left panels) and THP1 (data not shown) cells. Additionally, we were able to detect the processing of CagA in the human gastric cell line MKN-45 (Fig. 1C, right panels). The molecular mass of the smaller fragment in MKN-45 cells correlates with that of the p35CagA fragment detected in J774.A cells (Fig. 1C, stars).
Tyrosine-phosphorylated CagA has been shown to inhibit the tyrosine kinase c-Src in AGS gastric epithelial cells, which results in dephosphorylation of the Src substrates cortactin and ezrin (33, 35). We found that the dephosphorylation of host cell proteins did not occur in all cell lines where CagA phosphorylation could be detected. Only seven human cell lines showed this effect, namely, the gastric epithelial cell lines AGS, MKN-45, and Kato3, the human colon cell line HT29 (Fig. 1D), the endometrial cell line Hec1.b, the kidney epithelial cell line 293T, and the liver epithelial cell line HepG2 (data not shown). This dephosphorylation clearly depends on CagA, because it did not occur when cells were infected with an isogenic cagA knockout mutant.
Besides the translocation of CagA, the H. pylori TFSS has also been shown to mediate proinflammatory responses in a CagA-independent manner. We investigated this proinflammatory response by measuring IL-8 secretion into the cell culture supernatant during infection by ELISA (Fig. 2). We found that infection with wild-type H. pylori stimulated IL-8 secretion by all human cell lines except GLC4. Intriguingly, GLC4 was also the only human cell line in which CagA translocation could not be observed. Again, the inability of wild-type H. pylori to stimulate IL-8 secretion by GLC4 cells indicates that some degree of cell type specificity is involved in this process. It might also be possible that GLC4 cells have a general defect in IL-8 synthesis.
|
virB11 did not increase IL-8 secretion compared to that in noninfected controls. This result indicates that the proinflammatory response indeed largely depends on the H. pylori TFSS. Only HeLa and THP1 cells secreted a small amount of IL-8 in a virB11-independent manner. Therefore, these cell lines are apparently able to respond to H. pylori infection by an additional mechanism which does not depend on type IV secretion. However, TFSS-dependent IL-8 secretion is considerably stronger than TFSS-independent IL-8 secretion in both HeLa and THP1 cells. Since mice do not harbor an IL-8 gene, instead we determined the concentration of the functional analog Mip-2 in the supernatants of the four murine cell lines. We only detected Mip-2 secretion upon infection of the macrophage-like J774.A cells. Interestingly, Mip-2 secretion by these cells was independent of the TFSS, as the Mip-2 level induced by the virB11 knockout mutant was even slightly higher than that induced by wild-type bacteria.
CagA translocation has been shown to induce elongation and scattering of AGS gastric epithelial cells, which result in the formation of a striking cellular phenotype (hummingbird phenotype). We investigated changes in cell morphology after 20 h of infection with wild-type P1 or with the cagA and virB11 knockout mutants (Fig. 3; Table 2). Remarkably, only 2 of the 19 cell lines showed a clear change in morphology in response to H. pylori infection. As expected, we found that wild-type H. pylori induce the hummingbird phenotype of AGS cells. Neither infection with the cagA knockout strain nor that with the virB11 knockout strain caused the hummingbird phenotype, confirming that it depends on CagA translocation through the TFSS. When we infected the macrophage-like cell line THP1, we observed the formation of large cell aggregates. In contrast, noninfected cells grew mainly as a single cell suspension. Aggregation was found to be dependent on the TFSS, as it did not occur during infection with the virB11 knockout strain. CagA, however, appears to be dispensable because the cagA knockout mutant was still able to cause aggregation (data not shown). Apart from the frequently observed cellular vacuolization caused by the vacuolating cytotoxin VacA, we did not observe major changes in morphology or shape upon infection of the 17 other cell lines. Thus, changes in phenotype during infection are apparently the exception rather than the rule.
|
|
DISCUSSION |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Based on our data, we have compiled a model of the roles of host cell factors required for the cellular responses induced by the H. pylori TFSS. The first step where host cell factors appear to be involved is the translocation of CagA by the TFSS (Fig. 4A). Since we found that CagA is not translocated into all cell lines, the function of the TFSS obviously depends on a host cell factor(s). A possible explanation could be that a specific host cell receptor directly binds to components of the H. pylori TFSS. Alternatively, the type IV secretion machinery might be activated by specific host cell factors that are sensed by H. pylori.
|
Another interesting observation is that we were unable to detect major changes in cell morphology during the infection of most cell lines (Fig. 3). Specifically, we found that the hummingbird phenotype occurs only during infection of AGS gastric epithelial cells. Some molecular details showing how this striking phenotype is induced have recently emerged (Fig. 4C) (7). For example, phosphorylated CagA binds to the tyrosine phosphatase SHP-2 and the tyrosine kinase Csk (17, 40). Moreover, tyrosine-phosphorylated CagA inhibits the catalytic activity of c-Src, which results in the dephosphorylation of Src substrates, the actin binding proteins cortactin and ezrin (33, 35), and some other host cell proteins that have not yet been identified (6, 30). Finally, CagA was also shown to bind to Grb2 and c-Met and to disrupt the apical junction complexes of epithelial cells (1, 11, 22). Since these last events are independent of CagA tyrosine phosphorylation, however, it is unlikely that they play a direct role in the induction of the hummingbird phenotype, which strictly depends on CagA tyrosine phosphorylation (3).
The observation that the hummingbird phenotype is restricted to AGS cells indicates that some of the required factors are absent from other cell lines. It might also be possible that some cell lines possess inhibitory factors that are absent from AGS cells. Interestingly, we found that tyrosine dephosphorylation of host cell proteins is frequently observed in most cell lines where substantial CagA translocation occurs. Although we have not unambiguously identified these proteins, their apparent molecular weight suggests that they are identical to proteins that become dephosphorylated in AGS cells. Thus, it is improbable that differences in host protein dephosphorylation can account for the different phenotypic outcomes. Similarly, Csk and SHP-2 are ubiquitously expressed, indicating that they also are not the factors responsible for the differences (28, 39). Apparently, some pieces of this puzzle are still missing. It will be a challenge to identify the relevant factors in order to understand how the H. pylori CagA protein subverts the actin cytoskeleton in AGS cells.
The proinflammatory response is thought to be induced by the translocation of peptidoglycan by the H. pylori TFSS (41). In agreement with this model, we found that for all human cell lines tested, strong IL-8 secretion was only observed during infection with the wild-type strain P1, not with the virB11 knockout mutant. However, we observed a small but significant amount of IL-8 secretion upon infection of HeLa and THP1 cells with the virB11 mutant. This indicates that in these cells an additional mechanism exists which detects H. pylori and stimulates a proinflammatory response independent of type IV secretion, although to a much lower extent (Fig. 4D). Toll-like receptors (TLRs) are attractive candidates for alternative cellular sensors of H. pylori infection. While H. pylori flagellins fail to activate TLR5 (16, 20), intact bacteria were recently shown to activate TLR2 (21). Interestingly, infection of the murine macrophage-like cell line J774.A resulted in a strong cag PAI-independent secretion of Mip-2. This indicates that in mouse macrophages the alternative mechanisms of H. pylori-induced inflammation are much more pronounced.
Proinflammatory signaling induced by H. pylori results in the activation of the eukaryotic transcription factors NF-B and AP-1. This in turn up-regulates the expression of several proinflammatory cytokines and chemokines, including IL-8. In contrast to the case for the hummingbird phenotype, we found that all human cell lines positive for CagA translocation also secrete IL-8 (Table 2), suggesting that the Nod1 cascade is functional in many different cell types. Interestingly, neither IL-8 secretion nor CagA translocation was observed in GLC4 cells, suggesting that the same host cell factors might be required for both CagA and peptidoglycan translocation.
Besides IL-8 secretion, NF-B activation has also been shown to enhance the expression and surface exposure of intercellular cell adhesion molecule 1 (ICAM-1). ICAM-1 binds to its receptor, lymphocyte function-associated protein 1, on other cells, which results in the homotypic aggregation of H. pylori-infected cells growing in suspension (23). In agreement with this report, we observed a homotypic aggregation of THP1 cells.
Collectively, our results demonstrate that host cell factors play a critical role at different levels in cellular responses mediated by the H. pylori TFSS. Most interestingly, specific host cell factors are apparently required for the ability of H. pylori to translocate effector molecules into host cells. This is in marked contrast to the TFSSs of other pathogens. For example, the Dot/Icm system of Legionella pneumophila is able to inject effectors into both protozoa and mammalian cells (26). Similarly, the type IV machinery encoded by the tumor-inducing plasmid of Agrobacterium tumefaciens can deliver DNA into both plant cells and human cell lines (19).
There are several possibilities for how the observed host cell specificity of the responses induced by the H. pylori TFSS could be explained. One potential explanation is that specific host cell factors might be required to activate the TFSS. This activation could operate at the level of protein expression. For example, this is the case for the type III secretion system of Yersinia spp. (31). However, the abundant expression of CagA in the absence of host cells indicates that the translocation itself, rather than CagA expression, is repressed. Indeed, despite its abundant expression, CagA is not secreted without host cell contact (9). This is reminiscent of the situation in Shigella flexneri, where effector proteins are stored in the bacterial cytoplasm before contact with host cells. In this case, translocation is triggered by a variety of factors, such as extracellular matrix proteins, bile salts, and Congo red (18). In a similar manner, the H. pylori TFSS might be activated by a specific factor secreted by (or present on the surfaces of) only some host cells.
An alternative explanation is that a receptor on the host cell surface is required for the contact between components of the secretion system and the plasma membrane. In the case of A. tumefaciens, the VirE2 protein encoded by the bacterium forms a channel in the host cell membrane through which substrate translocation is thought to proceed (13). No such factor has yet been identified for H. pylori. It is tempting to speculate that H. pylori uses host cell proteins as membrane channels for the TFSS. Until now, however, there has been little experimental evidence in favor of this hypothesis. Interestingly, Amieva and coworkers were able to adapt H. pylori strain G27 to MDCK cells by 4 months of cocultivation (1). In contrast to the wild-type strain, the adapted bacteria were able to translocate a small but significant amount of CagA. Apparently, the high genetic variability of H. pylori allows the bacterium to change the specificity of its type IV secretion system within a rather short timescale.
In summary, our comparative analysis of different mammalian cell lines has revealed that unknown host cell factors are required for the function of the H. pylori TFSS. When extrapolated to the in vivo situation, these results support the notion that the disease outcome is not only determined by bacterial factors but also by host determinants. The identification of these factors will shed new light on the molecular details of the host-pathogen interaction and might help in the development of new therapeutic strategies to fight infection.
|
ACKNOWLEDGMENTS |
|---|
|
FOOTNOTES |
|---|
Present address: University of Southern Denmark, Center for Experimental BioInformatics, Department of Biochemistry and Molecular Biology, Campusvej 55, DK-5230 Odense M, Denmark.
|
REFERENCES |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
| 1. | Amieva, M. R., R. Vogelmann, A. Covacci, L. S. Tompkins, W. J. Nelson, and S. Falkow. 2003. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300:1430-1434. |
| 2. | Backert, S., Y. Churin, and T. F. Meyer. 2002. Helicobacter pylori type IV secretion, host cell signalling and vaccine development. Keio J. Med. 51(Suppl. 2):6-14. |
| 3. | Backert, S., S. Moese, M. Selbach, V. Brinkmann, and T. F. Meyer. 2001. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42:631-644.[CrossRef][Medline] |
| 4. | Backert, S., E. C. Muller, P. R. Jungblut, and T. F. Meyer. 2001. Tyrosine phosphorylation patterns and size modification of the Helicobacter pylori CagA protein after translocation into gastric epithelial cells. Proteomics 1:608-617.[CrossRef][Medline] |
| 5. | Backert, S., T. Schwarz, S. Miehlke, C. Kirsch, C. Sommer, T. Kwok, M. Gerhard, U. B. Goebel, N. Lehn, W. Koenig, and T. F. Meyer. 2004. Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect. Immun. 72:1043-1056. |
| 6. | Backert, S., E. Ziska, V. Brinkmann, U. Zimny-Arndt, A. Fauconnier, P. R. Jungblut, M. Naumann, and T. F. Meyer. 2000. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell. Microbiol. 2:155-164.[CrossRef][Medline] |
| 7. | Blaser, M. J., and J. C. Atherton. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Investig. 113:321-333.[CrossRef][Medline] |
| 8. | Blaser, M. J., and D. E. Berg. 2001. Helicobacter pylori genetic diversity and risk of human disease. J. Clin. Investig. 107:767-773.[Medline] |
| 9. | Bumann, D., S. Aksu, M. Wendland, K. Janek, U. Zimny-Arndt, N. Sabarth, T. F. Meyer, and P. R. Jungblut. 2002. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect. Immun. 70:3396-3403. |
| 10. | Cascales, E., and P. J. Christie. 2003. The versatile bacterial type IV secretion systems. Nat. Rev. Microbiol. 1:137-149.[CrossRef][Medline] |
| 11. | Churin, Y., L. Al-Ghoul, O. Kepp, T. F. Meyer, W. Birchmeier, and M. Naumann. 2003. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell Biol. 161:249-255. |
| 12. | Covacci, A., J. L. Telford, G. Del Giudice, J. Parsonnet, and R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284:1328-1333. |
| 13. | Dumas, F., M. Duckely, P. Pelczar, P. Van Gelder, and B. Hohn. 2001. An Agrobacterium VirE2 channel for transferred-DNA transport into plant cells. Proc. Natl. Acad. Sci. USA 98:485-490. |
| 14. | El-Omar, E. M., M. Carrington, W. H. Chow, K. E. McColl, J. H. Bream, H. A. Young, J. Herrera, J. Lissowska, C. C. Yuan, N. Rothman, G. Lanyon, M. Martin, J. F. Fraumeni, Jr., and C. S. Rabkin. 2001. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412:499.[CrossRef][Medline] |
| 15. | Fischer, W., J. Puls, R. Buhrdorf, B. Gebert, S. Odenbreit, and R. Haas. 2001. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol. Microbiol. 42:1337-1348.[CrossRef][Medline] |
| 16. | Gewirtz, A. T., Y. Yu, U. S. Krishna, D. A. Israel, S. L. Lyons, and R. M. Peek, Jr. 2004. Helicobacter pylori flagellin evades Toll-like receptor 5-mediated innate immunity. J. Infect. Dis. 189:1914-1920.[CrossRef][Medline] |
| 17. | Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686. |
| 18. | Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433. |
| 19. | Kunik, T., T. Tzfira, Y. Kapulnik, Y. Gafni, C. Dingwall, and V. Citovsky. 2001. Genetic transformation of HeLa cells by Agrobacterium. Proc. Natl. Acad. Sci. USA 98:1871-1876. |
| 20. | Lee, S. K., A. Stack, E. Katzowitsch, S. I. Aizawa, S. Suerbaum, and C. Josenhans. 2003. Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect. 5:1345-1356.[CrossRef][Medline] |
| 21. | Mandell, L., A. P. Moran, A. Cocchiarella, J. Houghton, N. Taylor, J. G. Fox, T. C. Wang, and E. A. Kurt-Jones. 2004. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect. Immun. 72:6446-6454. |
| 22. | Mimuro, H., T. Suzuki, J. Tanaka, M. Asahi, R. Haas, and C. Sasakawa. 2002. Grb2 is a key mediator of Helicobacter pylori CagA protein activities. Mol. Cell 10:745-755.[CrossRef][Medline] |
| 23. | Moese, S., M. Selbach, T. F. Meyer, and S. Backert. 2002. cag+ Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface. Infect. Immun. 70:4687-4691. |
| 24. | Moese, S., M. Selbach, U. Zimny-Arndt, P. R. Jungblut, T. F. Meyer, and S. Backert. 2001. Identification of a tyrosine-phosphorylated 35 kDa carboxy-terminal fragment (p35CagA) of the Helicobacter pylori CagA protein in phagocytic cells: processing or breakage? Proteomics 1:618-629.[CrossRef][Medline] |
| 25. | Moss, S. F., and S. Sood. 2003. Helicobacter pylori. Curr. Opin. Infect. Dis. 16:445-451.[CrossRef][Medline] |
| 26. | Nagai, H., and C. R. Roy. 2003. Show me the substrates: modulation of host cell function by type IV secretion systems. Cell. Microbiol. 5:373-383.[CrossRef][Medline] |
| 27. | Naito, Y., I. Kino, K. Horiuchi, and D. Fujimoto. 1984. Promotion of collagen production by human fibroblasts with gastric cancer cells in vitro. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 46:145-154. |
| 28. | Neel, B., H. Gu, and L. Pao. 2003. The 'Shp'ing news: SH2 domain containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 28:284-293.[CrossRef][Medline] |
| 29. | Odenbreit, S., B. Gebert, J. Puls, W. Fischer, and R. Haas. 2001. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and processing of CagA. Cell Microbiol. 3:21-31.[CrossRef][Medline] |
| 30. | Odenbreit, S., J. Puls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500. |
| 31. | Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustafsson, K. E. Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by pathogen target cell contact. Science 273:1231-1233.[Abstract] |
| 32. | Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559-14564. |
| 33. | Selbach, M., S. Moese, S. Backert, P. R. Jungblut, and T. F. Meyer. 2004. The Helicobacter pylori CagA protein induces tyrosine dephosphorylation of ezrin. Proteomics 4:2961-2968.[CrossRef][Medline] |
| 34. | Selbach, M., S. Moese, C. R. Hauck, T. F. Meyer, and S. Backert. 2002. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:6775-6778. |
| 35. | Selbach, M., S. Moese, R. Hurwitz, C. R. Hauck, T. F. Meyer, and S. Backert. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 22:515-528.[CrossRef][Medline] |
| 36. | Selbach, M., S. Moese, T. F. Meyer, and S. Backert. 2002. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect. Immun. 70:665-671. |
| 37. | Stein, M., F. Bagnoli, R. Halenbeck, R. Rappuoli, W. J. Fantl, and A. Covacci. 2002. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:971-980.[CrossRef][Medline] |
| 38. | Stoicov, C., R. Saffari, X. Cai, C. Hasyagar, and J. Houghton. 2004. Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 341:1-17.[CrossRef][Medline] |
| 39. | Thomas, S. M., and J. S. Brugge. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13:513-609.[CrossRef][Medline] |
| 40. | Tsutsumi, R., H. Higashi, M. Higuchi, M. Okada, and M. Hatakeyama. 2003. Attenuation of Helicobacter pylori CagA x SHP-2 signaling by interaction between CagA and C-terminal Src kinase. J. Biol. Chem. 278:3664-3670. |
| 41. | Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran, R. Athman, S. Memet, M. R. Huerre, A. J. Coyle, P. S. DiStefano, P. J. Sansonetti, A. Labigne, J. Bertin, D. J. Philpott, and R. L. Ferrero. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166-1174.[CrossRef][Medline] |
| 42. | Zijlstra, J. G., E. G. de Vries, and N. H. Mulder. 1987. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47:1780-1784. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|
